Research Grant
[Cite as https://purl.org/au-research/grants/nhmrc/1143687]Researchers: Prof Fabienne Mackay (Principal investigator) , Dr Constantine Tam
Brief description Chronic Lymphocytic Leukemia (CLL) is a very common blood cancer. CLL cells actively shut down immune defenses in patients. Moreover, current as well as emerging more targeted therapies suppress immunity and over a quarter of patients will die from an infection despite a good response to cancer treatments. Our laboratory has gained new understanding in the mechanism of action of a new treatment for CLL called Ibrutinib. This information allows us to design improved treatment options for CLL.
Funding Amount $AUD 886,704.46
Funding Scheme Project Grants
Notes Standard Project Grant
- nhmrc : 1143687
- PURL : https://purl.org/au-research/grants/nhmrc/1143687
